1-4 of 4
Tomohiro Sugawara
Close
Sort by
Journal Articles

The Prospective Analysis Of Clinical Efficacy and Adverse Events In Chronic Myeloid Leukemia In Chronic Phase (CML-CP) Patients With Imatinib Resistance Or Intolerance, Evaluated By European Leukemia Net (ELN) 2013 Criteria

Kazunori Murai, M.D., Ph.D., Tomoaki Akagi, M.D., Ph.D., Kenji Shimosegawa, MD, Kenichi Ishizawa, MD, PhD, Tomohiro Sugawara, MD, Hisayuki Yokoyama, MD, PhD, Hideyoshi Noji, MD, PhD, Kazuei Ogawa, M.D., Ph.D., Katsushi Tajima, MD, PhD, Koji Oba, PhD, Junichi Sakamoto, MD, PhD, Koumei Kubo, MD, PhD, Hisashi Sakamaki, MD, PhD, Hideo Harigae, MD, PhD, Yoji Ishida, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 4027.
https://doi.org/10.1182/blood.V122.21.4027.4027
Published: 2013
Journal Articles

Multicenter Phase II Clinical Trial of Nilotinib for Patients with Imatinib-Resistant or Intolerant CML From the East Japan CML Study Group (EJCML) Trial: Evaluation of Molecular Responses by the BCR-ABL1 Mutational Status and Plasma Trough Concentration of Nilotinib

Naoto Takahashi, MD, PhD, Masatomo Miura, PhD, Jun Kuroki, MD, PhD, Kinuko Mitani, MD, PhD, Atsushi Kitabayashi, MD, PhD, Osamu Sasaki, MD, PhD, Hideo Kimura, MD, PhD, Kiyotoshi Imai, MD, PhD, Norifumi Tsukamoto, MD, PhD, Hideyoshi Noji, MD, PhD, Takeshi Kondo, MD, PhD, Akihisa Kuwayama, MD, PhD, Mutsuhito Motegi, MD, PhD, Yuichi Kato, MD, PhD, Kaoru Takahashi, MD, PhD, Masayuki Mita, MD, PhD, Hajime Saito, MD, PhD, Chikashi Yoshida, MD, PhD, Yoshihiro Torimoto, MD, PhD, Tomofumi Kimura, MD, PhD, Yuji Wano, MD, PhD, Jun Nomura, MD, PhD, Satoshi Yamamoto, MD, PhD, Ko Mayama, MD, PhD, Riko Honma, MD, PhD, Tomohiro Sugawara, MD, PhD, Shinji Sato, MD, PhD, Atsushi Shinagawa, MD, PhD, Akihiko Chubachi, MD, PhD, Hideo Harigae, MD, PhD, Kenichi Sawada, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1360.
https://doi.org/10.1182/blood.V120.21.1360.1360
Published: 2012
Journal Articles

Efficacy and Safety of Dasatinib in Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP) with Imatinib Resistance or Intolerance

Tomoaki Akagi, MD, PhD, Kazunori Murai, MD, PhD, Kenji Shimosegawa, MD, Kenichi Ishizawa, MD, PhD, Tomohiro Sugawara, MD, Hisayuki Yokoyama, MD, PhD, Hideyoshi Noji, MD, PhD, Kazuei Ogawa, MD, Katsusi Tazima, MD, PhD, Koji Ooba, MD, Junichi Sakamoto, MD, PhD, Kubo Koumei, MD, PhD, Hisashi Sakamaki, MD, Hideo Harigae, MD, PhD, Yoji Ishida, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4444.
https://doi.org/10.1182/blood.V118.21.4444.4444
Published: 2011
Journal Articles

The GATA1 mutation in an adult patient with acute megakaryoblastic leukemia not accompanying Down syndrome

Hideo Harigae, Gang Xu, Tomohiro Sugawara, Izumi Ishikawa, Tsutomu Toki, Etsuro Ito
Journal: Blood
Blood (2004) 103 (8): 3242–3243.
https://doi.org/10.1182/blood-2004-01-0016
Published: 2004